ID   MUSIi001-A-2
AC   CVCL_D0JX
SY   HLA-I/II-null SFiPSCs
DR   BioSamples; SAMEA112466527
DR   hPSCreg; MUSIi001-A-2
DR   Wikidata; Q123033134
RX   PubMed=37343428;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Does not express HLA-I and II molecules (PubMed=37343428).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 7067; CIITA.
CC   Derived from site: In situ; Abdomen, skin, dermis; Note=From a cesarean section scar; UBERON=UBERON_0001416+UBERON_0002067.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0ZY ! MUSIi001-A-1
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=37343428; DOI=10.1016/j.scr.2023.103138;
RA   Thongsin N., Suwanpitak S., Wattanapanitch M.;
RT   "CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA
RT   class I and II expression in human induced pluripotent stem cells
RT   (MUSIi001-A-2).";
RL   Stem Cell Res. 71:103138-103138(2023).
//